1997
DOI: 10.1016/s0303-7207(96)03990-1
|View full text |Cite
|
Sign up to set email alerts
|

Recombinant rat follicle-stimulating hormone; production by Chinese hamster ovary cells, purification and functional characterization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
17
0
1

Year Published

1998
1998
2023
2023

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 34 publications
(19 citation statements)
references
References 30 publications
0
17
0
1
Order By: Relevance
“…With regard to LH, the lower bioactivity of rat LH was coupled with faster T Y value in the circulation of this hormone, as compared with the respective human hormone. In contrast, whereas rat recFSH had lower bioactivity (Hakola et al 1997a) and receptor affinity than the cognate human hormone, the T Y of the rat hormone was longer than that of the human hormone. In accordance, the elimination half-times of human recFSH were previously reported to be about 5·7 h in rats, but about 30 h in dogs and humans (de Leeuw et al 1996), which makes human FSH a suboptimal choice to study the physiology of FSH action in rats.…”
Section: Discussionmentioning
confidence: 82%
See 2 more Smart Citations
“…With regard to LH, the lower bioactivity of rat LH was coupled with faster T Y value in the circulation of this hormone, as compared with the respective human hormone. In contrast, whereas rat recFSH had lower bioactivity (Hakola et al 1997a) and receptor affinity than the cognate human hormone, the T Y of the rat hormone was longer than that of the human hormone. In accordance, the elimination half-times of human recFSH were previously reported to be about 5·7 h in rats, but about 30 h in dogs and humans (de Leeuw et al 1996), which makes human FSH a suboptimal choice to study the physiology of FSH action in rats.…”
Section: Discussionmentioning
confidence: 82%
“…The highly purified recombinant (rec) forms of rat LH (95% purity, 1100 IU/mg by in vitro bioassay, in relation to human recLH; Hakola et al 1997b) and FSH (98% purity, 8820 IU/mg by in vivo bioassay, Hakola et al 1997a) and of human FSH (Org 32489, >95% purity, 11 500 IU/mg by bioassay; batch 65), were donated by Organon (Organon International BV, Oss, The Netherlands). Highly purified human recLH (99·9% purity, 15 900 IU/ mg by in vivo bioassay, batch C31) was a generous gift of Ares-Serono (Geneva, Switzerland), and highly purified urinary hCG (NIH CR 121, 11 500 IU/mg) was a generous gift of NICDH (NIH, Bethesda, MD, USA).…”
Section: Hormone Preparationsmentioning
confidence: 99%
See 1 more Smart Citation
“…Biologically active recombinant FSH has been produced previously using transformed mammalian and insect cell lines and transgenic mice (Keene et al 1989, Greenberg et al 1991, Mountford et al 1994, Arey et al 1997, Hakola et al 1997). The CHO cell-derived recombinant human FSH has been used successfully in infertility treatment (Devroey et al 1993).…”
Section: Discussionmentioning
confidence: 99%
“…Placenta-derived material, such as PMSG, has the disadvantage of a very long biological half-life, which necessitates its neutralization by the injection of specific antibodies (Bouters et al 1983). Furthermore, stimulation of the target animal should preferably be with a homologous hormone preparation, as indicated by Hakola et al (1997). Finally, all currently used FSH preparations do contain some LH activity, which is considered responsible, at least in part, for the observed large variation in the results of superovulation (Kelly et al 1997).…”
Section: Introductionmentioning
confidence: 99%